Panacea Life Competitors
| PLSH Stock | USD 0.05 -0.0022 -4.40% |
Pair Correlation for Panacea Life and Anything Tech Overview
Very good diversification
PLSH currently posts a -0.4 correlation with EXMT, indicating a Very good diversification relationship for the active sample. The cleaner interpretation is to review correlation beside volatility, expected return, and the role each holding plays in the portfolio.
Moving against Panacea OTC Stock
Mean reversion in Panacea Life is more reliable over longer time horizons. Short-term deviations can persist and even widen before correcting, making position sizing and risk management critical.
Panacea Life Competition Correlation Matrix
Reviewing how Panacea Life Sciences moves relative to competing otcs can show whether peer exposure is reducing portfolio risk or simply repeating the same market bet. This matrix is most informative when investors want to know whether adding another peer would improve diversification, increase crowding, or leave total risk largely unchanged.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Panacea OTC Stock performing well and Panacea Life OTC Stock doing well as a business compared to the competition. A thorough review of Panacea Life's risk-adjusted indicators provides a clearer picture of whether returns are being earned efficiently. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| MJARF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| KOAN | 7.48 | -1.07 | 0.00 | -1.64 | 0.00 | 12.00 | 78.78 | |||
| CNNA | 63.14 | 26.88 | 0.00 | -0.46 | 0.00 | 0.00 | 2,033 | |||
| OWPC | 9.41 | -0.47 | 0.00 | 0.31 | 0.00 | 25.00 | 74.11 | |||
| CBDY | 5.00 | 0.28 | 0.02 | -0.29 | 7.32 | 11.76 | 57.79 | |||
| ALID | 2.85 | -1.41 | 0.00 | -1.31 | 0.00 | 0.00 | 95.50 | |||
| ANTCF | 0.53 | 0.27 | 0.00 | 0.68 | 0.00 | 0.00 | 0.00 | |||
| BHNGF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| JWCAF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| EXMT | 11.82 | 1.88 | 0.07 | 1.70 | 11.69 | 33.33 | 133.33 |
Panacea Life Competitive Analysis
How does Panacea Life measure up against MJardin, Textmunication Holdings, and Cann American? The financials tell a nuanced story. Panacea Life operates at a 3.3 M scale with 2.1 M flowing through the income statement. Panacea Life posts a -239.54% return on equity, reflecting current earnings headwinds. Market capitalization diverges sharply here: 3.3 M versus 90, giving Panacea Life a clear size advantage. Panacea Life leads on revenue, 2.1 M to 27,031, a substantial gap. Panacea Life converts shareholder equity more efficiently at -239.54% versus Cann American at -259.65%.| Better Than Average | Worse Than Peers | View Performance Chart |
Panacea Life Competition Peer Performance Charts
How to Analyze Panacea Life Against Peers
Panacea Life's peer analysis compares Panacea Life with related companies to put valuation, quality, and risk metrics in context. This helps determine whether recent performance is company-specific or broadly sector-driven. A practical workflow includes:- Set a relevant peer group: Include direct competitors and close alternatives with comparable business exposure.
- Benchmark core financials: Compare profitability, growth, capital structure, and cash flow quality.
- Check valuation dispersion: Review whether Panacea Life trades at a premium or discount versus peers and why.
- Evaluate risk profile: Compare volatility, drawdowns, and correlation to avoid false diversification assumptions.
- Document the thesis: Record where Panacea Life leads or lags and what catalysts could close or widen the gap.
Peer Comparison Metrics & Methodology
The competition view for Panacea Life includes correlation data, so you can see not only which peers are financially similar but also which ones move together in the market. The peer set can help frame whether recent outperformance is broad-based or company-specific. For peer comparison, Panacea Life has a market cap of 3.33 M.
The analytics block for Panacea Life Sciences relies on periodic company reporting and market reference feeds, with quality checks and normalization applied before rendering. Timing can vary by data vendor.